This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit
|   AhHa B2B Search:      Oct. 24, 2012

Home  About Us  Advocacy   CSHP 2015   Events   Membership   Products & Publications   Programs Resources   Contact Us


RxFiles Drug Comparison Charts


- Book: New 9th
  Editions
- Online:
www.RxFiles.ca
- Apps: iPad &
  Android



 




Disclaimer: CSHP e-Newsbrief is a weekly listing featuring the latest news in hospital pharmacy selected from thousands of sources by the editors of MultiView. CSHP personnel approve the final summaries: any comments regarding content or this new publication should be emailed to CSHP. The presence of advertising does not endorse, or imply endorsement of, any products or services by the CSHP. Neither MultiView nor CSHP is liable for any inaccuracies or the use of or reliance on any information contained in this briefing, with the exception of CSHP news items.



In this issue:

Death toll in U.S. fungal meningitis outbreak hits 23
Expanded pharmacist services will help local patients
When health insurance falls short in Canada
Ontario to spend $15 million on treatment for prescription drug addiction
Antidepressants may increase your risk of stroke
Methotrexate and heartburn drugs alert
New psychiatric drugs low priority for pharmaceutical firms
Samsung halts biosimilar rituximab trial on regulatory concerns
Changes in workflow help address near-miss errors
Canada-EU drug patent demand in trade talks costs almost $2 billion


Death toll in U.S. fungal meningitis outbreak hits 23
CTV News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
An outbreak of fungal meningitis has been linked to steroid shots for back pain. The medication, made by a specialty pharmacy in Massachusetts, has been recalled. The latest numbers of deaths and infections are from the Centers for Disease Control and Prevention. More



Expanded pharmacist services will help local patients
Barry's Bay This Week    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Expanded pharmacist services announced by the provincial government last week will improve local patients' access to certain healthcare needs. Premier Dalton McGuinty announced that, Ontario pharmacists can renew or adapt existing prescriptions, prescribe medication to help people quit smoking, demonstrate how to use an asthma inhaler or inject insulin and support patients who have a chronic disease, such as diabetes, monitor their condition. More

When health insurance falls short in Canada
The Vancouver Sun    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Noel Burke, dean of extended learning at Concordia University, subscribes to group health coverage available through work; but when his early-stage colon cancer was diagnosed this spring, his insurance company refused to pay for the medication his doctor had judged best to treat his condition. More

Manrex Complete Unit Dose Packaging

If your hospital is using automated dispensing cabinets or Bar Code Medication Administration at the bedside you should consider Pentapack unit dose packaging for your orals, liquids, suppositories and ampoules. Pentapack is a complete and inexpensive system which offers a variety of packaging and labelling formats. For information: 1.800.665.7652 info@manrex.com www.manrex.com
more


Ontario to spend $15 million on treatment for prescription drug addiction
CTV News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The Ontario government announced $15 million in new funding to help those battling addiction to prescription drugs receive treatment. Health Minister Deb Matthews said the funding will focus on pregnant women, mothers and those aboriginal communities who are addicted to opioids, such as the prescription painkiller OxyContin. More

Antidepressants may increase your risk of stroke
Medical Daily    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Antidepressants may treat your depression, but new research suggests they may also increase the risk of certain types of strokes. According to a study published in the journal Neurology, taking Lexapro, Zoloft or other common antidepressants has been linked to hemorrhagic strokes. More

Methotrexate and heartburn drugs alert
CBC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Labels for two types of medications — methotrexate, used to treat cancer and autoimmune disorders, and acid reducing proton pump inhibitors — will be updated to warn of a potential interaction, Health Canada says. More

New psychiatric drugs low priority for pharmaceutical firms
CBC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The pharmaceutical industry has largely abandoned drug development for mental illnesses even though depression is a leading cause of disability, experts say. Authors of papers published in a recent issue of the journal Science Translational Medicine argue that drug discovery for treating psychiatric disorders such as autism, schizophrenia, bipolar disorder and depression are at a near standstill. More



Samsung halts biosimilar rituximab trial on regulatory concerns
in-PharmaTechnologist    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Reports suggest that Samsung Biologics has halted a trial of a biosimilar version of Roche and Biogen Idec's Rituxan (rituximab). The paper suggested that concerns over biosimilars regulations in key markets is an issue. Samsung did not respond Outsourcing-pharma.com's request for further information. More

Changes in workflow help address near-miss errors
Pharmacy Practice News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Medication event reporting is a completely voluntary process at many institutions and is used frequently to document the specifics of medication events. The current process for reporting medication events at the Hospital of the University of Pennsylvania, part of the University of Pennsylvania Health System, is through an internal electronic database. More

Canada-EU drug patent demand in trade talks costs almost $2 billion
CBC News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Confidential federal research on free-trade talks with Europe shows that giving the European Union just one part of what it wants on drug patents would cost Canadians up to $2 billion a year. The Department of Foreign Affairs and International Trade has always insisted it's a 'myth' that the Canada-EU free trade deal would increase health costs. More


 


CSHP e-Newsbrief

Frank Humada, Director of Publishing, MultiView 289.695.5422
Download media kit

Siobhan Cole, Senior Content Editor, MultiView 289.695.5423   
Contribute news


To unsubscribe, click here.

Recent issues






50 Minthorn Blvd., Suite 800, Thornhill, ON, L3T 7X8